Netherlands

News from aidsmap

• Where did HIV come from, and when? And does it matter?

  Keith Alcorn | 05 March 2001

  After the concentrated controversy of the first day, the second day of the Royal Society's meeting on the origins of the HIV epidemic saw a starburst of further controversies regarding ...

• More tricky drug interactions: fine tuning HAART

  Keith Alcorn | 05 March 2001

  Highlights from the First International Workshop on Clinical Pharmacology of HIV Therapy, Noordwijk, The Netherlands, March 30-31, 2000. Using efavirenz with bid IDV/RTV 800/100mg ABT-378/r with other PIs Amprenavir and ritonavir Amprenavir/ritonavir and efavirenz Saquinavir ...

• Hepatitis B and C increase risk of liver toxicity after starting HAART

  Keith Alcorn | 05 March 2001

  Co-infection with hepatitis B and/or C, rather than the use of particular antiretrovirals, is the main factor predicting the risk of developing liver toxicity after starting HAART, according to researchers ...

• Therapeutic drug monitoring: quality control still needed, international study shows

  Keith Alcorn | 05 March 2001

  Highlights from the First International Workshop on Clinical Pharmacology of HIV Therapy, Noordwijk, The Netherlands, March 30-31, 2000. Therapeutic drug monitoring, although recommended in French and (implicitly) in UK treatment guidelines, ...

• Once daily dual PIs on horizon

  Anna Poppa | 05 March 2001

  According to preliminary experiments in HIV-negative volunteers, giving the protease inhibitors indinavir or saquinavir with low dose ritonavir might allow these dual PI combinations to be prescribed as once daily ...

• Therapeutic drug monitoring: better test for NRTIs?

  Keith Alcorn | 05 March 2001

  Highlights from the First International Workshop on Clinical Pharmacology of HIV Therapy, Noordwijk, The Netherlands, March 30-31, 2000. Therapeutic drug monitoring has largely focussed on protease inhibitors, partly because of large ...

• Developing countries could produce generic drugs right now, UNAIDS study reveals

  Anon | 05 March 2001

  In a dramatic development with significant implications for Access to Treatment, UNAIDS has released a study which indicates that AIDS medications are patented in hardly any of the world's developing ...

• Acetyl carnitine treatment for peripheral neuropathy

  Keith Alcorn | 05 March 2001

  Highlights from the First International Workshop on Clinical Pharmacology of HIV Therapy, Noordwijk, The Netherlands, March 30-31, 2000. L-acetyl carnitine, a substance which transports long chain fatty acids to the mitochondria ...